The Outlook For Precigen (NASDAQ:PGEN)
Precigen(US:PGEN) Seeking Alphaยท2025-09-23 22:18Group 1 - Precigen, Inc. (NASDAQ: PGEN) shares have significantly increased following the FDA's full approval of its recurrent respiratory papillomatosis therapy, Papzimeos, on August 14th, marking the first-ever approval for this indication [2] Group 2 - The Biotech Forum, led by Bret, offers a model portfolio featuring 12-20 high upside biotech stocks, along with live chat discussions on trade ideas and weekly market commentary [2]